thiazoles has been researched along with Bowel Diseases, Inflammatory in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Marafini, I; Monteleone, G; Salvatori, S; Troncone, E | 1 |
Blumberg, RS; Cheng, M; Han, X; Huang, Z; Nie, Y; Ren, K; Ruan, HB; Sahu, C; Wu, K; Xiong, X; Xu, B; Zhao, M | 1 |
Song, SD; Tang, HF | 1 |
Choi, HG; Dančík, V; Gagnon, J; Graham, DB; Gray, NS; Hussain, MM; Khor, B; Narayan, K; O'Connell, DJ; Perez, JR; Reinecker, HC; Russell, CN; Schreiber, SL; Shamji, AF; Song, JH; Sundberg, TB; Xavier, RJ | 1 |
Procoli, F | 1 |
Bickston, SJ; Kappus, MR; Snider, KR | 1 |
Gotham, S | 1 |
Clay, MP; Hanssen, BR; Lindstrom, TD; Surapaneni, SS | 1 |
Furitsu, H; Iga, T; Kotaki, H; Sawada, Y; Yamada, H | 2 |
Bailey, ST; Flanigan, A; Jiang, W; Keilbaugh, SA; Lazar, MA; Murthy, S; Rangwala, SM; Su, CG; Wen, X; Wu, GD | 1 |
Cai, TQ; Gan, X; Wong, B; Wright, SD | 1 |
3 review(s) available for thiazoles and Bowel Diseases, Inflammatory
Article | Year |
---|---|
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Oligonucleotides; Phosphodiesterase 4 Inhibitors; Thalidomide; Thiazoles; Transforming Growth Factor beta | 2020 |
[Progress in PDE4 targeted therapy for inflammatory diseases].
Topics: Aminopyridines; Aminoquinolines; Arthritis; Asthma; Benzamides; Cyclopropanes; Dermatitis; Humans; Inflammation; Inflammatory Bowel Diseases; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Sulfones; Thalidomide; Thiazoles | 2014 |
Tetomilast: new promise for phosphodiesterase-4 inhibitors?
Topics: Animals; Anti-Inflammatory Agents; Humans; Inflammatory Bowel Diseases; Phosphodiesterase 4 Inhibitors; Thiazoles | 2012 |
10 other study(ies) available for thiazoles and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Deficiency in intestinal epithelial O-GlcNAcylation predisposes to gut inflammation.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Colitis; Dysbiosis; Epithelial Cells; Fecal Microbiota Transplantation; Female; Homeostasis; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; N-Acetylglucosaminyltransferases; Paneth Cells; Protein Processing, Post-Translational; Pyrans; STAT Transcription Factors; Thiazoles | 2018 |
Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells.
Topics: Aniline Compounds; Animals; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cytokines; Dasatinib; Dendritic Cells; Drug Evaluation, Preclinical; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-10; Intestine, Small; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cells; Nitriles; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Quinolines; Signal Transduction; T-Lymphocytes, Regulatory; Thiazoles; Transcription Factors | 2014 |
Clinical trial on the efficacy of masitinib in canine IBD.
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Clinical Trials as Topic; Dog Diseases; Dogs; Inflammatory Bowel Diseases; Piperidines; Pyridines; Thiazoles; Treatment Outcome | 2010 |
Digestive Disease Week 2004. Bowel inflammation.
Topics: Azepines; Cholinergic Agents; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Isoquinolines; Pyridazines; Tacrolimus; Thiazoles | 2004 |
Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
Topics: Administration, Oral; Animals; Area Under Curve; Blood Proteins; Dogs; Female; Half-Life; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Microsomes, Liver; Phenols; Protein Binding; Rats; Rats, Inbred F344; Stereoisomerism; Sulfoxides; Thiazoles; Thiazolidines | 1999 |
Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemia.
Topics: Animals; Benzothiazoles; Disease Models, Animal; Inflammatory Bowel Diseases; Inulin; Kidney Tubules, Proximal; Lipoxygenase Inhibitors; Male; Pyridines; Rats; Rats, Wistar; Thiazoles; Thromboxane-A Synthase; Uric Acid; Uricosuric Agents | 1999 |
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.
Topics: Animals; Caco-2 Cells; Colitis; Cytokines; DNA-Binding Proteins; Epithelium; Gene Expression; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Inflammatory Bowel Diseases; Interleukin-8; Ligands; Mice; Microbodies; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
E 3040.
Topics: Animals; Benzothiazoles; Colitis, Ulcerative; Drugs, Investigational; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Lipoxygenase Inhibitors; Pyridines; Rats; Thiazoles; Thromboxane-A Synthase | 1999 |
Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice.
Topics: Animals; Benzothiazoles; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred DBA; Pyrazinamide; Pyridines; Thiazoles; Uric Acid; Uricosuric Agents | 1999 |
Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli.
Topics: Caco-2 Cells; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-1; Lipopolysaccharides; Matrix Metalloproteinase 9; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |